申请人:Allergan, Inc.
公开号:US20140228345A1
公开(公告)日:2014-08-14
The present invention relates to substituted pyrazole azetidines, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
本发明涉及替代吡唑吖唑啉,制备它们的方法,含有它们的药物组合物以及它们作为调节鞘氨醇-1-磷酸受体的药物的用途。